Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.456 USD | -2.36% | +20.00% | +67.03% |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 31.16M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -27M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.63
x | P/E ratio 2025 * |
-1.22
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.72% |
Latest transcript on Brainstorm Cell Therapeutics Inc.
1 day | -2.36% | ||
1 week | +20.00% | ||
Current month | +20.79% | ||
1 month | -20.98% | ||
3 months | +21.60% | ||
6 months | +167.61% | ||
Current year | +67.03% |
Managers | Title | Age | Since |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 07-06-30 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 12-12-22 |
Chief Tech/Sci/R&D Officer | - | 22-05-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 00-09-21 |
Uri Yablonka
BRD | Director/Board Member | 47 | 14-06-05 |
Jacob Frenkel
CHM | Chairman | 81 | 20-03-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.456 | -2.36% | 348,174 |
24-05-09 | 0.467 | +8.60% | 317,021 |
24-05-08 | 0.43 | +16.85% | 1,344,009 |
24-05-07 | 0.368 | -1.60% | 363,631 |
24-05-06 | 0.374 | -1.58% | 1,309,996 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.03% | 31.16M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- BCLI Stock